(28 days)
No
The description focuses on chemical reactions and color intensity measurement, with no mention of AI or ML terms or concepts.
No
Explanation: This device is for diagnostic purposes, specifically measuring HDL cholesterol for the diagnosis and treatment of lipid disorders. It does not directly provide therapy.
Yes
The "Intended Use / Indications for Use" section explicitly states that "Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases." This indicates the device provides information for diagnostic purposes.
No
The device description clearly states the device consists of "chemical reagents in dry form" and "test strips," which are physical components, not software. It also mentions being measured by a "CardioChek brand analyzer," implying a hardware component is necessary for its function.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states that the test strips are used to "measure high density lipoprotein cholesterol in whole blood." This measurement is used in the "diagnosis and treatment of lipid disorders... atherosclerosis, and various liver and renal diseases." This clearly indicates the device is used to examine specimens derived from the human body to provide information for diagnostic purposes.
- Device Description: The description details how the test strip works by reacting with whole blood to produce a color that is measured by an analyzer. This process is performed in vitro (outside the body).
- Regulatory Context: The presence of predicate and reference devices with K numbers (indicating FDA clearance) further supports that this device falls under the regulatory framework for medical devices, specifically IVDs given its function.
The definition of an IVD generally includes reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. This device fits that description.
N/A
Intended Use / Indications for Use
PTS PANELS HDL Cholesterol Test Strips are intended to measure high density lipoprotein cholesterol in whole blood. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.
Product codes
NAQ, LBR
Device Description
PTS PANELS HDL Cholesterol Test Strips consist of chemical reagents in dry form. When whole blood is placed on the test strip, only the HDL cholesterol fraction passes through to the reaction layer. The HDL cholesterol reacts with a dried cholesterol reagent to produce color. The HDL concentration is proportional to the intensity of the color developed and is measured by a CardioChek brand analyzer.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1175 Cholesterol (total) test system.
(a)
Identification. A cholesterol (total) test system is a device intended to measure cholesterol in plasma and serum. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
0
APR 5 2006
SECTION F: 510(k) Summary
510(k) SUMMARY
This summary of safety and effectiveness information is submitted in compliance with 21CFR807.92.
1. Application Date:
March 6, 2006
2. Applicant Information:
Polymer Technology Systems, Inc. 7736 Zionsville Road Indianapolis, IN 46268 Contact Person: Margo Enright Phone Number: 317-870-5610 FAX Number: 317-870-5608 e-mail: menright@cardiochek.com
3. Trade Names:
PTS PANELS HDL Cholesterol Test Strips
4. Description:
PTS PANELS HDL Cholesterol Test Strips consist of chemical reagents in dry form. When whole blood is placed on the test strip, only the HDL cholesterol fraction passes through to the reaction layer. The HDL cholesterol reacts with a dried cholesterol reagent to produce color. The HDL concentration is proportional to the intensity of the color developed and is measured by a CardioChek brand analyzer.
5. Classification Names:
Lipoprotein test system Panel: Clinical Chemistry 75 Product Codes: NAQ, LBR
6. Facility Address:
7736 Zionsville Road Indianapolis, IN 46268
7. Device Classification:
Class I (Regulations: 21 CFR 862.1175, 21 CFR 862.1475)
8. Intended Use:
PTS PANELS HDL Cholesterol Test Strips are intended to measure high density lipoprotein cholesterol in whole blood. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases. ... .. .. ... ................................................................................................................................................................
9. Reason for 510(k):
Device Modification
1
10. Predicate Device Information
The predicate devices for determination of substantial equivalence are: Name: PTS PANELS HDL Cholesterol Test Strips Device Company: Polymer Technology Systems, Inc. 510(k) Numbers: K990247 and K993377
Similarities and Differences between modified PTS PANELS HDL Cholesterol Test Strips and the Predicate Device (unmodified)
| Item | Predicates | Modified Device |
|---|---|---|
| Intended Use | Intended to measure HDL cholesterol in whole blood. | Same |
| Technology | Dry chemistry test strip for use with PTS reflectance photometer. | Same |
| Measuring Range | 25-85 mg/dL HDL Cholesterol | Same |
| Product Storage | Store with vial tightly capped in a cool dry place at room temperature of 68-86°F. | Same |
| Specimen | Whole blood from fingerstick or venous blood collected in EDTA or heparin tube. | Same |
| Chemistry Method | Enzymatic (cholesterol esterase/oxidase) trinder method for cholesterol. | Same |
| Calibration Curve | Resides on a read-only memory (EEPROM) chip packaged with the test strips. | Same |
| Differences Between Predicate and Modified Device | ||
| Item | Predicates | Modified Device |
| Chemistry Fractionation | Phosphotungstic acid precipitation method. | Dextran sulfate inhibiting method. |
| Blood | Contains glass fiber. | No glass fiber. |
Similarities Between Predicate and Modified Device
-
- Compliance with Special Controls
Separation membrane Analyzer
- Compliance with Special Controls
Used on MTM BioScanner
(K972669)
Used on BioScanner
Plus (K013173 and K014099), which is
marketed as CardioChek and CardioChek PA.
:
. .
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines forming its body and wings. The symbol is positioned inside a circular border, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the circumference of the circle.
Public Health Service
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
5 2006 APR
Ms. Margo Enright Manager of Clinical Affairs Polymer Technology Systems, Inc. 7736 Zionsville Road Indianapolis, IN 46268
Re: K060617
Trade/Device Name: PTS PANELS HDL Cholesterol Test Strips Regulation Number: 21 CFR§862.1175 Regulation Name: Cholesterol (total) test system Regulatory Class: Class I Product Code: NAQ, LBR Dated: March 6, 2006 Received: March 8, 2006
Dear Ms. Enright:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
3
Page 2 -
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Albert G. A.
Alberto Gutierrez, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known):
Device Name: PTS PANELS HDL Cholesterol Test Strips
PTS PANELS HDL Cholesterol Test Strips are intended to measure high density lipoprotein cholesterol in whole blood. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use X (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Carol Benson
__
Division Sign-Off
Division Sign-On
Office of In Vitro Diagnostic
Page 1 of
510(k) K040617